ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Field
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
Career Opportunities-Clinical&RA
Career Opportunities-BD
Career Opportunities-Preclinical
CONTACT
中文
|
EN
ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Field
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
Career Opportunities-Clinical&RA
Career Opportunities-BD
Career Opportunities-Preclinical
CONTACT
中文
EN
en2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Home
>
ABOUT SIMR
>
Milestones
>
2019
2019
en2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
July-SIMR initiated the first-in-human study of candidate drug SR419 for peripheral neuropathic pain
发布时间:2019年08月04日
上一篇:无
下一篇:暂无